| 6.16 Delayed Data As of Sep 20 |  +0.11 / +1.82%Today’s Change | 3.75 Today|||52-Week Range 16.19 | +8.26% Year-to-Date |
| The Zacks Analyst Blog Highlights: Anheuser-Busch, Tilray, Boston Beer, Constellation Brands and Aphria Sep 16 / Zacks.com - Paid Partner Content | Top 3 Cannabis Stocks to Buy Ahead of Canada's 2.0 Legalization Sep 05 / MotleyFool.com - Paid Partner Content |
| 4 Stocks to Ride on the CBD-Infused Beverage Trend Sep 13 / Zacks.com - Paid Partner Content |
| Previous close | 6.05 |
| Today’s open | 6.05 |
| Day’s range | 5.93 - 6.22 |
| Volume | 2,748,863 |
| Average volume (3 months) | 4,231,273 |
| Market cap | $1.5B |
| Earnings growth (last year) | -136.33% |
| Earnings growth (this year) | +255.91% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +517.73% |
| P/E ratio | NM |
| Price/Sales | 8.94 |
| Price/Book | 1.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| USNAUSANA Health Science... | -0.56 | -0.81% |
| HEXOHexo Corp | +0.42 | +10.66% |
| OGIOrganiGram Holdings ... | +0.03 | +0.72% |
| MTPMidatech Pharma PLC | +0.15 | +12.71% |
| Next reporting date | October 11, 2019 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $179.3M |
| Annual profit (last year) | -$12.5M |
| Net profit margin | -6.96% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Irwin David Simon |
Chief Operating Officer- Aphria Leamington James R. Meiers |
Corporate headquarters Leamington, Ontario |
